Saturday 17 October 2026
Export NXGL’s income statement to Excel — free account
NexGel, Inc.
NXGL Healthcare Medical Instruments & Supplies
NexGel, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.4 million, up 31.5% from fiscal 2024. In the quarter to June 2026, revenue grew 27.8%, EPS fell 344.4%, free cash flow fell 432.3% and total debt rose 353.8%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for five.
5.59
0.41
+7.92%
Follow NXGL
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 3 | 2 | 5 | 5 | 4 | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z-Score |
24.63 | 68.80 | 27.76 | 29.08 | 18.87 | — | — | — | — |
P/S ratio |
22.14 | 66.86 | 62.42 | 73.50 | 100.29 | 187.25 | 187.25 | 187.25 | — |
Altman Z″-Score (non-manufacturers) |
(6.91) | (4.63) | (4.38) | 1.35 | 4.53 | (13.13) | (14.82) | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Beneish M-Score |
(3.41) | (1.98) | (0.77) | (3.32) | (46.34) | — | — | — | — |
P/Operating CF |
900.00 | (676.22) | (434.82) | (231.93) | (129.95) | (401.00) | (401.00) | (401.00) | — |
P/B ratio |
51.71 | 95.54 | 49.41 | 19.71 | 12.87 | 433.31 | 433.31 | 433.31 | — |
Price to Tangible BV |
82.06 | 140.14 | 68.76 | 20.60 | 13.25 | 1,542.07 | 1,542.07 | 1,542.07 | — |
EV/Sales |
22.12 | 66.76 | 61.89 | 70.41 | 91.86 | 186.38 | 186.38 | 186.38 | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
(192.72) | (150.00) | (78.20) | (48.19) | (51.75) | (105.48) | (105.48) | (105.48) | — |
EV/FCF |
(174.49) | (134.58) | (64.36) | (48.60) | (47.15) | (82.54) | (82.54) | (82.54) | — |
Quick Ratio |
0.59 | 1.11 | 1.31 | 7.95 | 4.69 | 0.08 | 0.45 | 0.08 | — |
Current Ratio |
1.47 | 2.07 | 1.98 | 8.74 | 4.82 | 0.27 | 0.64 | 0.89 | — |
Net Debt/EBITDA |
0.13 | 0.32 | 0.67 | 3.32 | 24.97 | (0.10) | (0.35) | 0.00 | — |
Debt/Assets |
6.99% | 8.15% | 5.15% | 2.59% | 1.57% | 11.34% | 48.52% | 0.00% | 0.00% |
Debt/Equity |
0.15 | 0.15 | 0.10 | 0.04 | 0.02 | 3.61 | 2.41 | 0.00 | — |
Asset Turnover |
1.07 | 0.83 | 0.40 | 0.15 | 0.16 | 0.33 | 0.55 | 5.99 | — |
Operating CF/Net income |
0.44 | 1.18 | 1.03 | 0.63 | 0.64 | 0.80 | 0.94 | 0.82 | — |
Capex/Depreciation |
(0.09) | (0.67) | (3.08) | (0.07) | (0.13) | (6.00) | 0.00 | 0.00 | — |
Interest Coverage |
(98.59) | (43.88) | (231.80) | (2.51) | (1.33) | (282.50) | — | — | — |
| (54.69%) | (58.35%) | (49.32%) | (48.13%) | (70.91%) | (1,003.99%) | (581.85%) | (571.26%) | — | |
| (27.98%) | (31.34%) | (31.09%) | (34.72%) | (44.80%) | (109.19%) | (146.29%) | (510.96%) | — | |
ROIC |
(45.90%) | (42.98%) | (72.95%) | (161.46%) | 0.00% | (478.81%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
(89.90%) | (67.58%) | (78.89%) | (64.42%) | (36.64%) | 544.23% | (210.86%) | (1,225.97%) | — |
Average Days of Receivables |
21.51 | 39.20 | 56.50 | 39.57 | 49.18 | 39.53 | 51.92 | 5.61 | — |
Research and Development Expense of Revenue |
0.02% | 0.90% | 2.52% | 17.92% | 2.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
68.81% | 71.64% | 91.66% | 158.06% | 164.22% | 292.14% | 245.89% | 107.23% | — |
Intangible Assets out of Total Assets |
0.17 | 0.18 | 0.15 | 0.03 | 0.02 | 0.16 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
5.73% | 4.22% | 5.31% | 14.55% | 18.38% | 34.42% | 0.00% | 0.00% | — |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.03 | 0.06 | (0.01) | (0.01) | (0.01) | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(1.18%) | (0.56%) | (1.24%) | (3.15%) | (2.77%) | (2.69%) | (2.69%) | (2.69%) | — |
Free Cash Flow Yield |
(0.57%) | (0.74%) | (1.54%) | (1.97%) | (1.94%) | (1.21%) | (1.21%) | (1.21%) | — |
Revenue per Share |
1.45 | 1.33 | 0.72 | 0.37 | 0.52 | 0.30 | 0.05 | 0.44 | — |
Operating CF per Share |
(0.17) | (0.59) | (0.57) | (0.54) | (0.92) | (0.80) | (0.13) | (0.31) | — |
Capex per Share |
(0.01) | (0.07) | (0.12) | (0.02) | (0.09) | (0.14) | 0.00 | 0.00 | — |
Free Cash Flow per Share |
(0.18) | (0.66) | (0.69) | (0.55) | (1.01) | (0.94) | (0.13) | (0.31) | — |
Cash per Share |
0.13 | 0.28 | 0.48 | 1.19 | 4.48 | 0.01 | 0.02 | 0.00 | — |
Shareholders Equity per Share |
0.62 | 0.93 | 0.91 | 1.37 | 4.06 | 0.03 | 0.03 | 0.06 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
0.62 | 0.93 | 0.91 | 1.37 | 4.06 | 0.03 | 0.03 | 0.06 | — |
Free Cash Flow |
(1.38) | (4.31) | (3.93) | (3.09) | (3.02) | (2.11) | (1.81) | (1.54) | — |
Working Capital |
1.38 | 2.64 | 2.50 | 6.65 | 11.04 | (0.97) | (0.29) | (0.05) | — |
Capital Expenditures |
(0.07) | (0.44) | (0.70) | (0.10) | (0.27) | (0.31) | — | — | — |
Net Current Asset Value |
(1.23) | 0.21 | 0.26 | 4.79 | 9.03 | (1.82) | (1.00) | (0.10) | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.01 | 0.05 | 0.17 | 0.05 | 0.17 | 0.46 | 0.00 | 0.00 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.38 | 0.30 | 0.15 | 1.99 | 2.83 | 0.09 | 0.06 | 1.61 | — |
Cash ROIC |
(20.64%) | (49.08%) | (46.93%) | (21.28%) | (11.76%) | (588.58%) | (116.43%) | (549.47%) | — |
Accounts Receivable Turnover |
14.22 | 11.10 | 9.56 | 9.50 | 11.00 | 7.70 | 10.54 | 32.54 | — |
Accounts Payable Turnover |
5.36 | 4.71 | 4.96 | 6.91 | 3.38 | 1.65 | 2.63 | 5.18 | — |
Inventory Turnover |
3.58 | 3.87 | 4.08 | 4.52 | 5.89 | 5.58 | 8.21 | 16.15 | — |
Average Days of Payables |
68.07 | 79.39 | 121.14 | 53.98 | 60.08 | 248.88 | 212.02 | 33.16 | — |
Days of Inventory on Hand |
111.48 | 107.60 | 129.59 | 102.25 | 68.84 | 88.13 | 46.98 | 21.33 | — |
Average Receivables |
0.80 | 0.78 | 0.43 | 0.22 | 0.14 | 0.09 | 0.07 | 0.07 | — |
Average Payables |
1.29 | 1.26 | 0.75 | 0.26 | 0.46 | 0.58 | 0.33 | 0.33 | — |
Average Inventory |
1.93 | 1.54 | 0.91 | 0.40 | 0.26 | 0.17 | 0.11 | 0.11 | — |
Average Assets |
10.72 | 10.47 | 10.16 | 13.67 | 9.62 | 2.07 | 1.31 | 0.37 | — |
Average Common Equity |
5.49 | 5.62 | 6.40 | 9.86 | 6.08 | 0.23 | 0.33 | 0.33 | — |
Columns are period end dates